nodes	percent_of_prediction	percent_of_DWPC	metapath
Primidone—CYP2C8—Fluorouracil—head and neck cancer	0.0824	0.317	CbGbCtD
Primidone—Anaemia megaloblastic—Hydroxyurea—head and neck cancer	0.0759	0.142	CcSEcCtD
Primidone—CYP1A2—Fluorouracil—head and neck cancer	0.0638	0.245	CbGbCtD
Primidone—CYP2C9—Fluorouracil—head and neck cancer	0.0575	0.221	CbGbCtD
Primidone—CHRNA4—superior cervical ganglion—head and neck cancer	0.0408	0.347	CbGeAlD
Primidone—Systemic lupus erythematosus—Hydroxyurea—head and neck cancer	0.0323	0.0606	CcSEcCtD
Primidone—CYP3A4—Vinblastine—head and neck cancer	0.031	0.119	CbGbCtD
Primidone—Eruption—Hydroxyurea—head and neck cancer	0.0291	0.0546	CcSEcCtD
Primidone—Nystagmus—Vinblastine—head and neck cancer	0.0274	0.0515	CcSEcCtD
Primidone—CYP3A4—Docetaxel—head and neck cancer	0.0255	0.0981	CbGbCtD
Primidone—CHRNA4—cochlea—head and neck cancer	0.021	0.178	CbGeAlD
Primidone—Nystagmus—Fluorouracil—head and neck cancer	0.018	0.0338	CcSEcCtD
Primidone—Systemic lupus erythematosus—Docetaxel—head and neck cancer	0.0168	0.0315	CcSEcCtD
Primidone—Eruption—Docetaxel—head and neck cancer	0.0151	0.0283	CcSEcCtD
Primidone—Depression—Vinblastine—head and neck cancer	0.0109	0.0205	CcSEcCtD
Primidone—Agranulocytosis—Vinblastine—head and neck cancer	0.0102	0.0192	CcSEcCtD
Primidone—Drowsiness—Hydroxyurea—head and neck cancer	0.01	0.0188	CcSEcCtD
Primidone—Ataxia—Fluorouracil—head and neck cancer	0.00878	0.0165	CcSEcCtD
Primidone—Anaemia—Vinblastine—head and neck cancer	0.00792	0.0149	CcSEcCtD
Primidone—Vertigo—Vinblastine—head and neck cancer	0.0077	0.0145	CcSEcCtD
Primidone—Anaemia—Hydroxyurea—head and neck cancer	0.00722	0.0136	CcSEcCtD
Primidone—Visual disturbance—Docetaxel—head and neck cancer	0.00712	0.0134	CcSEcCtD
Primidone—Agranulocytosis—Fluorouracil—head and neck cancer	0.00672	0.0126	CcSEcCtD
Primidone—Anorexia—Vinblastine—head and neck cancer	0.00667	0.0125	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00661	0.0124	CcSEcCtD
Primidone—Ataxia—Docetaxel—head and neck cancer	0.00634	0.0119	CcSEcCtD
Primidone—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00626	0.0117	CcSEcCtD
Primidone—Skin disorder—Hydroxyurea—head and neck cancer	0.0062	0.0116	CcSEcCtD
Primidone—Anorexia—Hydroxyurea—head and neck cancer	0.00608	0.0114	CcSEcCtD
Primidone—Decreased appetite—Vinblastine—head and neck cancer	0.00608	0.0114	CcSEcCtD
Primidone—GABRA3—neck—head and neck cancer	0.00569	0.0484	CbGeAlD
Primidone—Somnolence—Hydroxyurea—head and neck cancer	0.00567	0.0106	CcSEcCtD
Primidone—Decreased appetite—Hydroxyurea—head and neck cancer	0.00555	0.0104	CcSEcCtD
Primidone—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00551	0.0103	CcSEcCtD
Primidone—Fatigue—Hydroxyurea—head and neck cancer	0.0055	0.0103	CcSEcCtD
Primidone—Anaemia—Fluorouracil—head and neck cancer	0.0052	0.00976	CcSEcCtD
Primidone—Asthenia—Vinblastine—head and neck cancer	0.00502	0.00942	CcSEcCtD
Primidone—Agranulocytosis—Docetaxel—head and neck cancer	0.00485	0.0091	CcSEcCtD
Primidone—CHRNA7—neck—head and neck cancer	0.0048	0.0408	CbGeAlD
Primidone—Dizziness—Vinblastine—head and neck cancer	0.00463	0.00868	CcSEcCtD
Primidone—Connective tissue disorder—Docetaxel—head and neck cancer	0.00458	0.0086	CcSEcCtD
Primidone—Asthenia—Hydroxyurea—head and neck cancer	0.00458	0.00859	CcSEcCtD
Primidone—Nervous system disorder—Fluorouracil—head and neck cancer	0.0045	0.00845	CcSEcCtD
Primidone—Visual impairment—Docetaxel—head and neck cancer	0.0045	0.00844	CcSEcCtD
Primidone—Vomiting—Vinblastine—head and neck cancer	0.00445	0.00835	CcSEcCtD
Primidone—Headache—Vinblastine—head and neck cancer	0.00438	0.00822	CcSEcCtD
Primidone—Anorexia—Fluorouracil—head and neck cancer	0.00438	0.00821	CcSEcCtD
Primidone—Eye disorder—Docetaxel—head and neck cancer	0.00436	0.00818	CcSEcCtD
Primidone—Dizziness—Hydroxyurea—head and neck cancer	0.00422	0.00792	CcSEcCtD
Primidone—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00418	0.00785	CcSEcCtD
Primidone—Nausea—Vinblastine—head and neck cancer	0.00416	0.0078	CcSEcCtD
Primidone—Mental disorder—Docetaxel—head and neck cancer	0.00409	0.00767	CcSEcCtD
Primidone—Somnolence—Fluorouracil—head and neck cancer	0.00408	0.00766	CcSEcCtD
Primidone—Malnutrition—Docetaxel—head and neck cancer	0.00406	0.00762	CcSEcCtD
Primidone—Vomiting—Hydroxyurea—head and neck cancer	0.00406	0.00761	CcSEcCtD
Primidone—Rash—Hydroxyurea—head and neck cancer	0.00402	0.00755	CcSEcCtD
Primidone—Dermatitis—Hydroxyurea—head and neck cancer	0.00402	0.00754	CcSEcCtD
Primidone—Headache—Hydroxyurea—head and neck cancer	0.004	0.0075	CcSEcCtD
Primidone—Decreased appetite—Fluorouracil—head and neck cancer	0.00399	0.00749	CcSEcCtD
Primidone—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00396	0.00744	CcSEcCtD
Primidone—Nausea—Hydroxyurea—head and neck cancer	0.00379	0.00711	CcSEcCtD
Primidone—Anaemia—Docetaxel—head and neck cancer	0.00375	0.00704	CcSEcCtD
Primidone—CHRFAM7A—trachea—head and neck cancer	0.00357	0.0304	CbGeAlD
Primidone—Arthralgia—Docetaxel—head and neck cancer	0.00346	0.00649	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00343	0.00644	CcSEcCtD
Primidone—Nervous system disorder—Docetaxel—head and neck cancer	0.00325	0.0061	CcSEcCtD
Primidone—Skin disorder—Docetaxel—head and neck cancer	0.00322	0.00604	CcSEcCtD
Primidone—Anorexia—Docetaxel—head and neck cancer	0.00316	0.00593	CcSEcCtD
Primidone—Dizziness—Fluorouracil—head and neck cancer	0.00304	0.0057	CcSEcCtD
Primidone—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00302	0.00567	CcSEcCtD
Primidone—Somnolence—Docetaxel—head and neck cancer	0.00295	0.00553	CcSEcCtD
Primidone—Vomiting—Fluorouracil—head and neck cancer	0.00292	0.00548	CcSEcCtD
Primidone—Rash—Fluorouracil—head and neck cancer	0.0029	0.00543	CcSEcCtD
Primidone—Dermatitis—Fluorouracil—head and neck cancer	0.00289	0.00543	CcSEcCtD
Primidone—Decreased appetite—Docetaxel—head and neck cancer	0.00288	0.00541	CcSEcCtD
Primidone—Headache—Fluorouracil—head and neck cancer	0.00288	0.0054	CcSEcCtD
Primidone—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00286	0.00537	CcSEcCtD
Primidone—Fatigue—Docetaxel—head and neck cancer	0.00286	0.00536	CcSEcCtD
Primidone—CHRFAM7A—thyroid gland—head and neck cancer	0.00283	0.024	CbGeAlD
Primidone—GRIA2—head—head and neck cancer	0.00275	0.0234	CbGeAlD
Primidone—Nausea—Fluorouracil—head and neck cancer	0.00273	0.00512	CcSEcCtD
Primidone—GABRA3—thyroid gland—head and neck cancer	0.00271	0.023	CbGeAlD
Primidone—GABRA6—head—head and neck cancer	0.00266	0.0226	CbGeAlD
Primidone—GABRA5—head—head and neck cancer	0.00258	0.0219	CbGeAlD
Primidone—CHRFAM7A—head—head and neck cancer	0.00251	0.0213	CbGeAlD
Primidone—GRIK2—head—head and neck cancer	0.00249	0.0212	CbGeAlD
Primidone—GABRA3—head—head and neck cancer	0.0024	0.0204	CbGeAlD
Primidone—Asthenia—Docetaxel—head and neck cancer	0.00238	0.00446	CcSEcCtD
Primidone—GABRA4—head—head and neck cancer	0.00234	0.0199	CbGeAlD
Primidone—CHRNA7—thyroid gland—head and neck cancer	0.00228	0.0194	CbGeAlD
Primidone—Dizziness—Docetaxel—head and neck cancer	0.00219	0.00411	CcSEcCtD
Primidone—Vomiting—Docetaxel—head and neck cancer	0.00211	0.00395	CcSEcCtD
Primidone—Rash—Docetaxel—head and neck cancer	0.00209	0.00392	CcSEcCtD
Primidone—Dermatitis—Docetaxel—head and neck cancer	0.00209	0.00392	CcSEcCtD
Primidone—Headache—Docetaxel—head and neck cancer	0.00208	0.0039	CcSEcCtD
Primidone—CHRNA7—head—head and neck cancer	0.00203	0.0172	CbGeAlD
Primidone—CHRNA4—head—head and neck cancer	0.002	0.017	CbGeAlD
Primidone—Nausea—Docetaxel—head and neck cancer	0.00197	0.00369	CcSEcCtD
Primidone—GABRB2—head—head and neck cancer	0.00196	0.0167	CbGeAlD
Primidone—GABRG2—head—head and neck cancer	0.00196	0.0167	CbGeAlD
Primidone—GABRA2—head—head and neck cancer	0.00179	0.0152	CbGeAlD
Primidone—GABRA1—head—head and neck cancer	0.00173	0.0147	CbGeAlD
Primidone—CYP2B6—lymphoid tissue—head and neck cancer	0.00127	0.0108	CbGeAlD
Primidone—GABRA2—lymph node—head and neck cancer	0.00125	0.0107	CbGeAlD
Primidone—CYP1A2—thyroid gland—head and neck cancer	0.0012	0.0102	CbGeAlD
Primidone—CYP2B6—head—head and neck cancer	0.00102	0.00867	CbGeAlD
Primidone—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000377	0.00421	CbGpPWpGaD
Primidone—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000375	0.00419	CbGpPWpGaD
Primidone—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000371	0.00414	CbGpPWpGaD
Primidone—GABRB2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000363	0.00406	CbGpPWpGaD
Primidone—CYP2C8—Biological oxidations—NAT2—head and neck cancer	0.000362	0.00405	CbGpPWpGaD
Primidone—CYP2C8—Metapathway biotransformation—NAT2—head and neck cancer	0.000357	0.00399	CbGpPWpGaD
Primidone—GABRA5—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000353	0.00395	CbGpPWpGaD
Primidone—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000351	0.00393	CbGpPWpGaD
Primidone—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000347	0.00388	CbGpPWpGaD
Primidone—GABRA3—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000347	0.00387	CbGpPWpGaD
Primidone—GABRA2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000341	0.00381	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000339	0.00378	CbGpPWpGaD
Primidone—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000339	0.00378	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000339	0.00378	CbGpPWpGaD
Primidone—GABRG2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000332	0.00371	CbGpPWpGaD
Primidone—CYP2C19—Biological oxidations—NAT2—head and neck cancer	0.000323	0.00361	CbGpPWpGaD
Primidone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00032	0.00358	CbGpPWpGaD
Primidone—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00032	0.00358	CbGpPWpGaD
Primidone—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000319	0.00357	CbGpPWpGaD
Primidone—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000319	0.00356	CbGpPWpGaD
Primidone—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	0.000319	0.00356	CbGpPWpGaD
Primidone—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000317	0.00354	CbGpPWpGaD
Primidone—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000316	0.00353	CbGpPWpGaD
Primidone—CHRNA7—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000296	0.0033	CbGpPWpGaD
Primidone—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.000295	0.00329	CbGpPWpGaD
Primidone—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000291	0.00325	CbGpPWpGaD
Primidone—GABRA1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000291	0.00325	CbGpPWpGaD
Primidone—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.00029	0.00324	CbGpPWpGaD
Primidone—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000285	0.00318	CbGpPWpGaD
Primidone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000274	0.00306	CbGpPWpGaD
Primidone—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000271	0.00303	CbGpPWpGaD
Primidone—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00027	0.00302	CbGpPWpGaD
Primidone—GRIA2—BDNF signaling pathway—STAT3—head and neck cancer	0.000262	0.00293	CbGpPWpGaD
Primidone—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000261	0.00292	CbGpPWpGaD
Primidone—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00026	0.0029	CbGpPWpGaD
Primidone—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000256	0.00286	CbGpPWpGaD
Primidone—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000252	0.00281	CbGpPWpGaD
Primidone—GRIA2—BDNF signaling pathway—MAPK3—head and neck cancer	0.000251	0.0028	CbGpPWpGaD
Primidone—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000248	0.00278	CbGpPWpGaD
Primidone—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000244	0.00272	CbGpPWpGaD
Primidone—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000242	0.0027	CbGpPWpGaD
Primidone—CHRNA4—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000241	0.00269	CbGpPWpGaD
Primidone—GRIK2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.00024	0.00268	CbGpPWpGaD
Primidone—GRIA2—BDNF signaling pathway—MAPK1—head and neck cancer	0.000238	0.00266	CbGpPWpGaD
Primidone—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000236	0.00264	CbGpPWpGaD
Primidone—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000233	0.0026	CbGpPWpGaD
Primidone—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000222	0.00248	CbGpPWpGaD
Primidone—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000221	0.00246	CbGpPWpGaD
Primidone—CHRNA7—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000218	0.00244	CbGpPWpGaD
Primidone—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.000213	0.00238	CbGpPWpGaD
Primidone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000211	0.00236	CbGpPWpGaD
Primidone—CYP2B6—Biological oxidations—GSTM1—head and neck cancer	0.000211	0.00236	CbGpPWpGaD
Primidone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000209	0.00233	CbGpPWpGaD
Primidone—CYP2B6—Metapathway biotransformation—GSTM1—head and neck cancer	0.000208	0.00233	CbGpPWpGaD
Primidone—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000203	0.00227	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000201	0.00225	CbGpPWpGaD
Primidone—CYP2B6—Biological oxidations—CYP1A1—head and neck cancer	0.0002	0.00224	CbGpPWpGaD
Primidone—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.0002	0.00224	CbGpPWpGaD
Primidone—CYP2B6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000198	0.00221	CbGpPWpGaD
Primidone—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000196	0.00219	CbGpPWpGaD
Primidone—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000194	0.00217	CbGpPWpGaD
Primidone—GRIK2—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000192	0.00215	CbGpPWpGaD
Primidone—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000192	0.00214	CbGpPWpGaD
Primidone—GRIA2—BDNF signaling pathway—HRAS—head and neck cancer	0.000191	0.00214	CbGpPWpGaD
Primidone—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.00019	0.00212	CbGpPWpGaD
Primidone—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000188	0.00211	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000187	0.00209	CbGpPWpGaD
Primidone—GRIK2—Neuronal System—MAPK1—head and neck cancer	0.000184	0.00205	CbGpPWpGaD
Primidone—GRIA2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000183	0.00205	CbGpPWpGaD
Primidone—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000183	0.00205	CbGpPWpGaD
Primidone—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	0.000179	0.002	CbGpPWpGaD
Primidone—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000178	0.00199	CbGpPWpGaD
Primidone—CHRNA4—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000178	0.00199	CbGpPWpGaD
Primidone—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	0.000176	0.00197	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—UROD—head and neck cancer	0.000176	0.00197	CbGpPWpGaD
Primidone—CHRNA7—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000175	0.00196	CbGpPWpGaD
Primidone—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000175	0.00195	CbGpPWpGaD
Primidone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000172	0.00192	CbGpPWpGaD
Primidone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000171	0.00191	CbGpPWpGaD
Primidone—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	0.00017	0.00189	CbGpPWpGaD
Primidone—GRIA2—BDNF signaling pathway—AKT1—head and neck cancer	0.000169	0.00189	CbGpPWpGaD
Primidone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000168	0.00187	CbGpPWpGaD
Primidone—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000167	0.00187	CbGpPWpGaD
Primidone—CHRNA7—Neuronal System—MAPK1—head and neck cancer	0.000167	0.00187	CbGpPWpGaD
Primidone—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000163	0.00182	CbGpPWpGaD
Primidone—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000161	0.0018	CbGpPWpGaD
Primidone—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	0.00016	0.00178	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000159	0.00177	CbGpPWpGaD
Primidone—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	0.000157	0.00176	CbGpPWpGaD
Primidone—GABRA6—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000152	0.0017	CbGpPWpGaD
Primidone—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	0.000151	0.00169	CbGpPWpGaD
Primidone—GABRA4—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000151	0.00168	CbGpPWpGaD
Primidone—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000149	0.00167	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000149	0.00167	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—UROD—head and neck cancer	0.000149	0.00167	CbGpPWpGaD
Primidone—GRIK2—Neuronal System—HRAS—head and neck cancer	0.000147	0.00165	CbGpPWpGaD
Primidone—GRIA2—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000147	0.00164	CbGpPWpGaD
Primidone—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000147	0.00164	CbGpPWpGaD
Primidone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000146	0.00164	CbGpPWpGaD
Primidone—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	0.000146	0.00163	CbGpPWpGaD
Primidone—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	0.000144	0.0016	CbGpPWpGaD
Primidone—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000143	0.0016	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.000143	0.0016	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.000143	0.0016	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.000143	0.0016	CbGpPWpGaD
Primidone—CHRNA4—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000143	0.00159	CbGpPWpGaD
Primidone—GRIA2—Neuronal System—MAPK1—head and neck cancer	0.00014	0.00157	CbGpPWpGaD
Primidone—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.00014	0.00157	CbGpPWpGaD
Primidone—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	0.000138	0.00154	CbGpPWpGaD
Primidone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000138	0.00154	CbGpPWpGaD
Primidone—GABRB2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000138	0.00154	CbGpPWpGaD
Primidone—CHRNA4—Neuronal System—MAPK1—head and neck cancer	0.000136	0.00152	CbGpPWpGaD
Primidone—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000136	0.00152	CbGpPWpGaD
Primidone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000134	0.0015	CbGpPWpGaD
Primidone—CHRNA7—Neuronal System—HRAS—head and neck cancer	0.000134	0.0015	CbGpPWpGaD
Primidone—GABRA5—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000134	0.00149	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—UROD—head and neck cancer	0.000133	0.00149	CbGpPWpGaD
Primidone—GABRA3—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000131	0.00147	CbGpPWpGaD
Primidone—GABRA2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000129	0.00144	CbGpPWpGaD
Primidone—GABRG2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000126	0.00141	CbGpPWpGaD
Primidone—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	0.000124	0.00139	CbGpPWpGaD
Primidone—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	0.000123	0.00137	CbGpPWpGaD
Primidone—GABRA6—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000122	0.00137	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—UROD—head and neck cancer	0.000121	0.00136	CbGpPWpGaD
Primidone—GABRA4—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000121	0.00135	CbGpPWpGaD
Primidone—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	0.000118	0.00132	CbGpPWpGaD
Primidone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000118	0.00131	CbGpPWpGaD
Primidone—GABRA6—Neuronal System—MAPK1—head and neck cancer	0.000117	0.00131	CbGpPWpGaD
Primidone—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000116	0.0013	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000116	0.00129	CbGpPWpGaD
Primidone—GABRA4—Neuronal System—MAPK1—head and neck cancer	0.000115	0.00129	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.000115	0.00128	CbGpPWpGaD
Primidone—GRIA2—Neuronal System—HRAS—head and neck cancer	0.000113	0.00126	CbGpPWpGaD
Primidone—GABRB2—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000111	0.00124	CbGpPWpGaD
Primidone—GABRA1—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.00011	0.00123	CbGpPWpGaD
Primidone—CHRNA4—Neuronal System—HRAS—head and neck cancer	0.000109	0.00122	CbGpPWpGaD
Primidone—GABRA5—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000107	0.0012	CbGpPWpGaD
Primidone—GABRB2—Neuronal System—MAPK1—head and neck cancer	0.000105	0.00118	CbGpPWpGaD
Primidone—GABRA3—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000105	0.00118	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—UROD—head and neck cancer	0.000104	0.00116	CbGpPWpGaD
Primidone—GABRA2—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000104	0.00116	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000103	0.00115	CbGpPWpGaD
Primidone—GABRA5—Neuronal System—MAPK1—head and neck cancer	0.000102	0.00115	CbGpPWpGaD
Primidone—GABRG2—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000101	0.00113	CbGpPWpGaD
Primidone—GABRA3—Neuronal System—MAPK1—head and neck cancer	0.000101	0.00112	CbGpPWpGaD
Primidone—GABRA2—Neuronal System—MAPK1—head and neck cancer	9.89e-05	0.00111	CbGpPWpGaD
Primidone—GABRG2—Neuronal System—MAPK1—head and neck cancer	9.65e-05	0.00108	CbGpPWpGaD
Primidone—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	9.6e-05	0.00107	CbGpPWpGaD
Primidone—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	9.47e-05	0.00106	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	9.42e-05	0.00105	CbGpPWpGaD
Primidone—GABRA6—Neuronal System—HRAS—head and neck cancer	9.38e-05	0.00105	CbGpPWpGaD
Primidone—GABRA4—Neuronal System—HRAS—head and neck cancer	9.26e-05	0.00103	CbGpPWpGaD
Primidone—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	9.1e-05	0.00102	CbGpPWpGaD
Primidone—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	8.98e-05	0.001	CbGpPWpGaD
Primidone—GABRA1—Transmission across Chemical Synapses—HRAS—head and neck cancer	8.84e-05	0.000987	CbGpPWpGaD
Primidone—GABRB2—Neuronal System—HRAS—head and neck cancer	8.47e-05	0.000946	CbGpPWpGaD
Primidone—GABRA1—Neuronal System—MAPK1—head and neck cancer	8.43e-05	0.000942	CbGpPWpGaD
Primidone—GABRA5—Neuronal System—HRAS—head and neck cancer	8.23e-05	0.000919	CbGpPWpGaD
Primidone—GABRA3—Neuronal System—HRAS—head and neck cancer	8.08e-05	0.000903	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	8.05e-05	0.000899	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—UROD—head and neck cancer	8.01e-05	0.000895	CbGpPWpGaD
Primidone—GABRA2—Neuronal System—HRAS—head and neck cancer	7.94e-05	0.000887	CbGpPWpGaD
Primidone—GABRG2—Neuronal System—HRAS—head and neck cancer	7.75e-05	0.000865	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—NAT2—head and neck cancer	7.32e-05	0.000817	CbGpPWpGaD
Primidone—GABRA1—Neuronal System—HRAS—head and neck cancer	6.77e-05	0.000756	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	6.58e-05	0.000735	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	6.51e-05	0.000728	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—DPYD—head and neck cancer	6.41e-05	0.000717	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—NAT2—head and neck cancer	6.19e-05	0.000692	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—YAP1—head and neck cancer	6.09e-05	0.00068	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.87e-05	0.000656	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	5.81e-05	0.000649	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—NAT2—head and neck cancer	5.53e-05	0.000618	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—DPYD—head and neck cancer	5.43e-05	0.000607	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.35e-05	0.000598	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	5.3e-05	0.000592	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—YAP1—head and neck cancer	5.15e-05	0.000576	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—NAT2—head and neck cancer	5.04e-05	0.000563	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—DPYD—head and neck cancer	4.85e-05	0.000542	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—YAP1—head and neck cancer	4.6e-05	0.000514	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.57e-05	0.000511	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.53e-05	0.000506	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—DPYD—head and neck cancer	4.42e-05	0.000494	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—NAT2—head and neck cancer	4.31e-05	0.000481	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—YAP1—head and neck cancer	4.19e-05	0.000469	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.87e-05	0.000433	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—DPYD—head and neck cancer	3.78e-05	0.000422	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—TYMS—head and neck cancer	3.66e-05	0.000408	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—GSTM1—head and neck cancer	3.61e-05	0.000404	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—YAP1—head and neck cancer	3.58e-05	0.0004	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—GPX1—head and neck cancer	3.46e-05	0.000387	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.46e-05	0.000386	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—CYP1A1—head and neck cancer	3.43e-05	0.000383	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.38e-05	0.000377	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—NAT2—head and neck cancer	3.32e-05	0.000371	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.15e-05	0.000352	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—TYMS—head and neck cancer	3.09e-05	0.000346	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—GSTM1—head and neck cancer	3.06e-05	0.000342	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.01e-05	0.000337	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—GPX1—head and neck cancer	2.93e-05	0.000327	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—DPYD—head and neck cancer	2.92e-05	0.000326	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—CYP1A1—head and neck cancer	2.9e-05	0.000324	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—YAP1—head and neck cancer	2.77e-05	0.000309	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—TYMS—head and neck cancer	2.76e-05	0.000309	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.75e-05	0.000307	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—GSTM1—head and neck cancer	2.73e-05	0.000305	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.69e-05	0.000301	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—GPX1—head and neck cancer	2.61e-05	0.000292	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—CYP1A1—head and neck cancer	2.59e-05	0.000289	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—TYMS—head and neck cancer	2.52e-05	0.000281	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—GSTM1—head and neck cancer	2.49e-05	0.000278	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—GPX1—head and neck cancer	2.38e-05	0.000266	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.38e-05	0.000266	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—CYP1A1—head and neck cancer	2.36e-05	0.000264	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.35e-05	0.000262	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—TYMS—head and neck cancer	2.15e-05	0.00024	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—GSTM1—head and neck cancer	2.13e-05	0.000238	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.13e-05	0.000238	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—GPX1—head and neck cancer	2.04e-05	0.000228	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PTGS2—head and neck cancer	2.04e-05	0.000228	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CYP1A1—head and neck cancer	2.02e-05	0.000225	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.94e-05	0.000217	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PTEN—head and neck cancer	1.78e-05	0.000198	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PTGS2—head and neck cancer	1.72e-05	0.000193	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—TYMS—head and neck cancer	1.66e-05	0.000186	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.66e-05	0.000185	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.64e-05	0.000183	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—GPX1—head and neck cancer	1.57e-05	0.000176	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.56e-05	0.000174	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PTGS2—head and neck cancer	1.54e-05	0.000172	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PTEN—head and neck cancer	1.5e-05	0.000168	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PTGS2—head and neck cancer	1.4e-05	0.000157	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PTEN—head and neck cancer	1.34e-05	0.00015	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PIK3CA—head and neck cancer	1.25e-05	0.00014	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PTEN—head and neck cancer	1.22e-05	0.000137	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PTGS2—head and neck cancer	1.2e-05	0.000134	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PIK3CA—head and neck cancer	1.06e-05	0.000119	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PTEN—head and neck cancer	1.05e-05	0.000117	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—AKT1—head and neck cancer	1.02e-05	0.000114	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PIK3CA—head and neck cancer	9.47e-06	0.000106	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PTGS2—head and neck cancer	9.26e-06	0.000103	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—AKT1—head and neck cancer	8.67e-06	9.68e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PIK3CA—head and neck cancer	8.64e-06	9.65e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PTEN—head and neck cancer	8.07e-06	9.02e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—AKT1—head and neck cancer	7.74e-06	8.64e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PIK3CA—head and neck cancer	7.38e-06	8.24e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—AKT1—head and neck cancer	7.05e-06	7.88e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—AKT1—head and neck cancer	6.03e-06	6.74e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PIK3CA—head and neck cancer	5.69e-06	6.36e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—AKT1—head and neck cancer	4.65e-06	5.2e-05	CbGpPWpGaD
